Hyperion Therapeutics Inc (NASDAQ:HPTX)

During the Trading Day
45.98 +3.24 / +7.58%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
45.98 0.00 / 0.00%
 
Volume: 24.8K
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Sofinnova Ventures Inc
Sale6/04/2014417,747$27.70$11.6M+56.87%
Sofinnova Ventures Inc
Sale6/04/2014417,747$27.70$11.6M+56.87%
Scharschmidt Bruce F
Chief Medical Officer & Senior Vice President
Sale2/27/201524,996$29.79$744.6K+55.60%
Nash Christine A
Chief Commercial Officer & Senior Vice President
Sale3/17/201510,000$37.56$375.6K+14.86%
Nash Christine A
Chief Commercial Officer & Senior Vice President
Sale3/10/201510,000$35.08$350.8K+40.10%
Nash Christine A
Chief Commercial Officer & Senior Vice President
Sale3/09/20155,650$29.32$165.7K+53.99%
Scharschmidt Bruce F
Chief Medical Officer & Senior Vice President
Sale2/27/20154,804$30.43$146.2K+55.60%
Nash Christine A
Chief Commercial Officer & Senior Vice President
Sale3/09/20152,800$30.00$84.0K+53.99%
Nash Christine A
Chief Commercial Officer & Senior Vice President
Sale1/20/20152,500$25.27$63.2K+83.19%
Nash Christine A
Chief Commercial Officer & Senior Vice President
Sale1/20/20152,500$24.36$60.9K+83.19%
Page of 6

To view my watchlist

Not a member yet?

Sign up now for a free account